News | News By Subject | News by Disease News By Date | Search News

Anemia (misc) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
FibroGen (FGEN) Gets $62 Million License Payment from Partner AstraZeneca PLC (AZN)     7/8/2016
Keryx (KERX)'s Anemia Drug Ferric Citrate Succeeds in Phase III Study of Kidney Patients     3/29/2016
Amgen (AMGN)'s Aranesp Meets Primary Goal in Late Stage Trial     2/16/2016
Cambridge's Akebia (AKBA) Grabs an Asian Partner and Funding for Anemia Pill in $350 Million Deal     12/14/2015
Investors Nervous Over bluebird bio (BLUE)'s Latest Gene Therapy Updates Released Ahead of American Society of Hematology Conference     11/9/2015
Akebia Therapeutics, Inc. (AKBA)'s Lead Drug Successful in Mid-Stage Study     9/9/2015
GlaxoSmithKline (GSK) CEO Confident Investors Will Be Pleased With Pipeline on Nov. R&D Day     7/30/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
FDA Says Yes to Rockwell Medical (RMTI)'s Iron Replacement Drug     1/27/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Tug-Of-War Over Revlimid Patent Continues Between Celgene (CELG), Natco Pharma Limited     10/24/2014
Akebia Therapeutics, Inc. (AKBA), Trading M&A For An IPO—Becoming A Huge Contender In Anemia Drug Race     6/9/2014
American Regent Inc.'s Injectafer® (ferric carboxymaltose injection) Receives FDA Approval for the Treatment of Iron Deficiency Anemia     7/26/2013
Takeda Pharmaceutical Co. Ltd. (TKPYY) Recalls Batch of Anemia Therapy Rienso in Switzerland After Patient Death     5/22/2013

News from Around the Web
How A Celgene (CELG)-Partnered Drug Trial Could Save Struggling Acceleron Pharma     6/14/2017
Placing A Finger Over Your Smartphone Flash Could Soon Reveal A Low Red Blood Cell Count, University of Washington Study     9/9/2016
3-D Printed Device That Quickly Detect Anemia From Blood Developed By Kansas State University Researchers     2/26/2016
Anemia Linked To Mild Cognitive Impairment, Study Published In Journal Of Alzheimer's Disease     12/17/2015
Is Hummus Good For You? 6 Health Issues The Superfood Dip Can Treat     3/31/2015
Anemia Linked to Increased Risk of Dementia, University of California, San Francisco (UCSF) Study     8/1/2013
Loss of Essential Blood Cell Gene Leads to Anemia, Brigham and Women's Hospital Study     11/8/2012
Poor Eating Habits May Lead to Anemia in Older Women, University of Arizona Study     3/25/2011
Poor Response to Anti-Anemia Drug Predicts Higher Risk of Heart Disease Or Death, UT Southwestern Medical Center Study     12/29/2010
Telomeres Tell Future in Aplastic Anemia, National Institutes of Health (NIH) Study     9/22/2010
Key Step in Body's Ability to Make Red Blood Cells Discovered, UT Southwestern Medical Center Study     8/2/2010
Roche Holding AG (RHHBF.PK), Johnson & Johnson (JNJ) and Biogen Idec, Inc. (Massachusetts) (BIIB) Prodded by FDA for More Neglected Disease Medicines     6/18/2010
Anemia Drugs Help End-Stage Anemic Kidney Patients, Stanford University School of Medicine Study     3/3/2010
FDA Pleads for More Research on Anemia Drugs     1/7/2010
Columbia-Presbyterian Medical Center Study Confirms Clot Risks With Anti-Anemia Drugs     11/11/2009

Press Releases
Akebia (AKBA), Vifor Pharma Strike $50 Million Exclusive Anemia Drug Pact     5/16/2017
Apellis Pharma Receives EMA Orphan Drug Designation For APL-2 In PNH     5/9/2017
NIH Study In The New England Journal of Medicine Shows Novartis Drug Eltrombopag As First-Line Therapy With Standard Treatment Improves Responses In Severe Aplastic Anemia     4/20/2017
NIH Study In The New England Journal of Medicine Shows Novartis AG (NVS) Drug Eltrombopag As First-Line Therapy With Standard Treatment Improves Responses In Severe Aplastic Anemia     4/20/2017
Akebia (AKBA) Announces Publication Of Phase IIa Results For Vadadustat In Patients With Anemia Related To Chronic Kidney Disease     3/28/2017
Pieris Surged on $82.75 Million Anemia Drug Deal     2/28/2017
FibroGen (FGEN)'s Novel Anemia Treatment Meets Phase III Endpoints In China     1/31/2017
Apellis Pharma Announces FDA Fast Track Designation For APL-2 In PNH     12/20/2016
bluebird bio (BLUE) Announces First Patient Treated With LentiGlobin Drug Product In Northstar-2 (HGB-207) Phase III Trial Of Patients With Transfusion-Dependent ?-Thalassemia     12/14/2016
Agios (AGIO) Announces New Data From AG-348 And AG-519 Demonstrating Potential For First Disease-Modifying Treatment For Patients With PK Deficiency     12/5/2016
Apellis Pharma Reports Positive Interim Results From Phase Ib Clinical Trials Of APL-2 In PNH     12/2/2016
PhaseRx (PZRX) Receives Orphan Drug Designation From FDA For PRX-OTC For The Treatment Of Ornithine Transcarbamylase Deficiency     11/28/2016
Keryx (KERX) Announces Multiple Scientific Presentations Of Phase III Trial Results Of Ferric Citrate For Iron Deficiency Anemia (IDA) In Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD)     11/18/2016
True North Therapeutics Receives FDA Orphan Drug Designation For TNT009 For The Treatment Of Autoimmune Hemolytic Anemia, Including Cold Agglutinin Disease (CAD)     10/13/2016
Xenetic Biosciences Reports Positive Topline Data From Third Cohort Of Phase 2 Dose-Escalation Trial Of Erepoxen For Anemia     10/10/2016

//-->